Integrated continuous production of recombinant therapeutic proteins.
In the current environment of diverse product pipelines, rapidly fluctuating market demands and growing competition from biosimilars, biotechnology companies are increasingly driven to develop innovative solutions for highly flexible and cost-effective manufacturing. To address these challenging demands, integrated continuous processing, comprised of high-density perfusion cell culture and a directly coupled continuous capture step, can be used as a universal biomanufacturing platform. This study reports the first successful demonstration of the integration of a perfusion bioreactor and a four-column periodic counter-current chromatography (PCC) system for the continuous capture of candidate protein therapeutics. Two examples are presented: (1) a monoclonal antibody (model of a stable protein) and (2) a recombinant human enzyme (model of a highly complex, less stable protein). In both cases, high-density perfusion CHO cell cultures were operated at a quasi-steady state of 50-60 × 10(6) cells/mL for more than 60 days, achieving volumetric productivities much higher than current perfusion or fed-batch processes. The directly integrated and automated PCC system ran uninterrupted for 30 days without indications of time-based performance decline. The product quality observed for the continuous capture process was comparable to that for a batch-column operation. Furthermore, the integration of perfusion cell culture and PCC led to a dramatic decrease in the equipment footprint and elimination of several non-value-added unit operations, such as clarification and intermediate hold steps. These findings demonstrate the potential of integrated continuous bioprocessing as a universal platform for the manufacture of various kinds of therapeutic proteins.
Commercial Process Development, Genzyme - A Sanofi Company, 45 New York Ave, Framingham, Massachusetts 01701, USA. veena.warikoo@genzyme.com
Veena
V
Warikoo
Rahul
R
Godawat
Kevin
K
Brower
Sujit
S
Jain
Daniel
D
Cummings
Elizabeth
E
Simons
Timothy
T
Johnson
Jason
J
Walther
Marcella
M
Yu
Benjamin
B
Wright
Jean
J
McLarty
Kenneth P
KP
Karey
Chris
C
Hwang
Weichang
W
Zhou
Frank
F
Riske
Konstantin
K
Konstantinov
D000818:Animals; D000911:Antibodies, Monoclonal / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D019149:Bioreactors; D001709:Biotechnology / Q000295:instrumentation* / Q000379:methods*; D016466:CHO Cells; D002452:Cell Count; D018929:Cell Culture Techniques / Q000295:instrumentation* / Q000379:methods*; D003377:Countercurrent Distribution; D006224:Cricetinae; D003412:Cricetulus; D004798:Enzymes / Q000096:biosynthesis / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism; D006801:Humans; D008954:Models, Biological; D010477:Perfusion; D011994:Recombinant Proteins / Q000096:biosynthesis* / Q000737:chemistry / Q000302:isolation & purification / Q000378:metabolism
D000911:Antibodies, Monoclonal; D004798:Enzymes; D011994:Recombinant Proteins